Press Releases

  Nouveau Monde Graphite Inc. ("NMG" or the "Company") (NMG, NOU, FSE: NM9A) is pleased to announce the appointment of Lapo Pistelli to its Board of Directors, effective immediately. Mr. Pistelli joins NMG's Board at a pivotal time for the Company, with construction underway at the Matawinie Mine and work advancing toward a targeted Final Investment Decision in the coming months for its 13ktpy Bécancour Battery Material Plant. "I am delighted to welcome Mr. Pistelli to NMG’s Board of Directors," said Daniel Buron, Chair of NMG’s Board of Directors. "His experience navigating complex geopolitical environments and fostering strategic partnerships across global markets will be a valuable

Collaboration adds the nPulse™ Vybrance™ System to patient care at the Hospital for Endocrine Surgery and supports generation of additional clinical data Pulse Biosciences, Inc. (NASDAQ:PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced a partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida. The partnership covers both the commercial use of the nPulse™ Vybrance™ Percutaneous Electrode System in the treatment of patients at the center and a clinical collaboration to generate additional data on the use of nsPFA energy in benign thyroid nodule t

Corsair Gaming, Inc. (NASDAQ:CRSR) ("Corsair" or the "Company"), a leading global provider and innovator of high-performance products for gamers, streamers, content-creators, performance PC builders, and SIM Racing enthusiasts, today announced it will release its third quarter 2026 results and financial outlook after the Nasdaq close on Thursday, November 5, 2026, with its management hosting a conference call to discuss results at 2:00 p.m. Pacific Time that same day. The 2:00 p.m. Pacific Time conference call will be accessible on Corsair’s Investor Relations website at https://ir.corsair.com, or by dialing 1-877-407-0784 (USA) or 1-201-689-8560 (International) with conference ID 1376226

Entegris, Inc. (NASDAQ:ENTG), a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries, today announced that its board of directors has authorized a quarterly cash dividend of $0.10 per share to be paid on November 18, 2026, to shareholders of record on the close of business on October 28, 2026. ABOUT ENTEGRIS Entegris is a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris has approximately 7,700 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in

Insurer expands Shekar Pannala’s role as chief information officer to include Data and Artificial Intelligence Chief Claims Officer Stephen Deane’s role expanded to include Operations James M. Yanosy, current chief financial officer for Business Insurance, Employee Benefits, Claims and centralized services, named chief risk officer The Hartford announced expanded roles for two key executives, and appointed a new chief risk officer, in a leadership and organizational change that will take effect Nov. 2. Data and Artificial Intelligence will be combined with the Technology organization, under Chief Information Officer Shekar Pannala’s leadership. Chief Claims Officer Stephen Deane w

Ategrity Specialty Insurance Company Holdings (NYSE:ASIC) (the "Company") announced today that it will release financial results for the third quarter ended September 30, 2026, after the market closes on Wednesday, October 21, 2026. These documents will be available on the Company’s Investor Relations website at https://investors.ategrity.com. The Company will host a conference call to discuss its results on the same day, Wednesday, October 21, 2026, beginning at 5:00 p.m. Eastern Time. Interested parties may access the conference call via a live webcast, which can be accessed at https://events.q4inc.com/attendee/664734151 or by visiting the Company’s Investor Relations website. Please jo

MGP Ingredients, Inc. (NASDAQ:MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, today announced it plans to report results for the third quarter of 2026 prior to the opening of the Nasdaq market on Wednesday, October 28. On that day, Julie Francis, president and CEO, and Brandon Gall, CFO, will host a conference call at 10 a.m. ET to discuss the results, provide a general business update and answer questions. Please visit the News and Events section of the company’s Investor Relations site to access the webcast. Investors can also dial (844) 308-6398 or (412) 717-9605 (international) to listen to the call. A replay will be available on the company

Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced it will report results for the third quarter 2026 after market close on Wednesday, November 4, 2026. Aeva will host a conference call and webcast to discuss the third quarter 2026 results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. Event: Aeva Technologies, Inc. Third Quarter 2026 Results Call Date: Wednesday, November 4, 2026 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Join by webcast: investors.aeva.com An archive of the webcast will be available shortly after the call on our investor relations website investors.aeva.com for 12 months following the c

First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales Increased 289% Reiterates Expectation of Flat to Modest Revenue Growth for FY 27 Reflecting Timing of Several Large Orders Recent New Record Orders Significantly Increases Revenue Visibility for FY 28 MILTON, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (NASDAQ:SOTK), a leading developer and manufacturer of precision ultrasonic coating systems, today reported financial results for the second quarter and first half of fiscal year 2027, ended August 31, 2026. Second Quarter Fiscal 2027 Highlights Net sales increased 1% to $5.23 million comp

Event to feature executive presentations, a product and service showcase, and opportunities to engage with VSE’s broader leadership team VSE Corporation ("VSE" or the "Company") (NASDAQ:VSEC, VSECU)), a leading provider of aviation aftermarket distribution and repair services, announced today that it will host its 2026 Investor Day in New York City on Wednesday, December 9, 2026, beginning at 9:00 a.m. ET. The event will combine executive presentations and a Q&A session with an in-person showcase of VSE Aviation’s product and service capabilities. In-person attendees will also have time to engage directly with the Company’s broader leadership team for a closer look at VSE’s businesses a

-- Company to receive ELEVATE-44-201 data from Cohort 1 open-label period by year-end 2026 -- -- ELEVATE-44-201 Cohort 2 enrollment complete with data expected in Q1 2027 -- BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (NASDAQ:TRDA) today announced that an independent Data Monitoring Committee (DMC), per study protocol, has reviewed all available safety and PK data from the eight participants enrolled in Cohort 2 of the double-blind, placebo-controlled, multiple ascending dose (MAD) portion of ELEVATE-44-201. The DMC recommended initiating Cohort 3 at the top dose of 18 mg/kg, an increase from 12 mg/kg in Cohort 2 and 6 mg/kg in Cohort 1. ELEVATE-44-201 is a Phase

- Findings from healthy volunteers in the Phase 1/1b trial will be shared at ACAAI 2026 Annual Scientific Meeting - Previous non-clinical studies demonstrated the potential for ZL-1503 to provide rapid itch relief and reduce inflammation in atopic diseases - Investor conference call and webcast to discuss data being presented at ACAAI and clinical trial plans scheduled for Friday, November 13 at 8:00 a.m. ET / 9:00 p.m. HKT Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)) today announced that data from the first clinical trial evaluating ZL-1503, the company’s internally developed interleukin-13 (IL-13) and interleukin-31 (IL-31)Rα bispecific antibody, will be shared for the first time at the A

Palmer Square Capital BDC Inc. (NYSE:PSBD) ("Palmer Square" or the "Company"), an externally managed business development company, today announced that it will release its financial results for the third quarter ended September 30, 2026, before the market opens on Wednesday, November 4, 2026. Palmer Square will host a conference call at 1:00 pm ET that day to review its financial performance and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Palmer Square Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The call can be accessed through the following

New York, NY, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Alpha Compute Corp. (NASDAQ:ALP) ("Alpha Compute" or the "Company"), a pioneering technology leader in Sovereign Superintelligence, today announced that it has signed a binding contract with a billion-dollar AI compute marketplace for a four-year, $81.7 million AI compute agreement. The agreement covers all 592 liquid-cooled NVIDIA B300 GPUs of the Company’s ALPHA-03 cluster in Missouri, USA with delivery targeted by early Q1 2027. The customer has paid a $1.0 million data center booking deposit. The customer is a venture-backed AI compute marketplace. According to the client, it was valued at more than $1 billion in a recent funding round an

EATONTOWN, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Climb, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:CLMB), today announced a distribution agreement with Netwrix, a global data and identity security company trusted by more than 13,000 organizations. The agreement gives Climb's VARs and MSPs access to Netwrix solutions, including the 1Secure™ platform, so they can help customers protect sensitive data and control who can access it across hybrid and AI-driven environments. Security is one of Climb's core focus areas, and organizations are under growing pressure to protect sensitive data and control access to it as th

Acquisition reflects company’s commitment to providing highest quality drinking water service Essential Utilities, Inc. (NYSE:WTRG) announced today its Aqua New Jersey subsidiary has finalized its $113,000 purchase of the water system assets of the Lake Tamarack Water Corporation in Sussex County. The system serves approximately 255 customers in the Lake Tamarack portion of Hardyston Township. The New Jersey Board of Public Utilities (NJ BPU) approved the acquisition on September 9, 2026. "We are well positioned to make much needed improvements to this system in order to ensure the highest-quality drinking water service," said Essential Utilities Chairman & CEO Christopher Franklin. "We

Performance Food Group Company (PFG) (NYSE:PFGC) will host a live audio webcast at 9 a.m. ET Wednesday, November 4, 2026, to discuss first-quarter fiscal 2027 financial results. PFG will issue a news release with those results at approximately 7 a.m. ET that same day. Scott McPherson, PFG President & Chief Executive Officer and Patrick Hatcher, Executive Vice President & Chief Financial Officer will discuss the company’s first-quarter fiscal 2027 results and answer questions from the investment community and news media. The webcast will be available in listen-only mode at investors.pfgc.com. Pre-event registration is necessary. An archived copy of the webcast will be available later tha

-- Cohort 1 met the primary objectives of favorable safety and tolerability at the initial dose of 5 mg/kg -- -- ENTR-601-45 plasma exposures were consistent with those predicted based on juvenile non-human primate exposure data -- -- In line with expectations, the secondary objectives demonstrated a 0.10% mean increase in dystrophin production versus baseline in treated participants at the initial dose of 5 mg/kg -- -- Company expects a significant increase in dystrophin production and functional benefit in future cohorts while maintaining a convenient Q6W dosing schedule -- -- ELEVATE-45-201 Cohort 2 enrollment is complete and the Company is on track to report data at the increased dos

SANTA MONICA, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE:MAC) Schedules Third Quarter 2026 Earnings Release and Conference Call WHEN: Earnings Results will be released after market on Wednesday, November 4, 2026. Management will hold a conference call at 2:00 pm Pacific Time (5:00 pm Eastern Time) on that same day to discuss quarterly results. PARTICIPANT DIAL-IN INFORMATION: The conference call can be accessed live over the phone by dialing the following numbers: United States (Toll Free): +1 833-862-0076 International: +1 412-564-6523 PARTICIPANT LIVE WEBCAST: https://edge.media-server.com/mmc/p/a6kizwzw REBROADCAST: Following the live webcast, a replay will be

BROOMFIELD, Colo., Oct. 14, 2026 (GLOBE NEWSWIRE) -- DMC Global Inc. (NASDAQ:BOOM) will report financial results for its third quarter ended September 30, 2026, after the stock market closes on Tuesday, October 27, 2026. Management will host a conference call and simultaneous webcast to discuss the results. The conference call will begin at 5 p.m. Eastern (3 p.m. Mountain) and will be accessible by dialing 877-407-5783 (or +1-201-689-8782 for international callers). A live webcast of the conference call will be available at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Zwh2pOGa A replay of the webcast will be available on the Investor Relations page of DMC’s website fo